Sangamo Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $121.7M | $10.2M |
| FY2014 | — | $206.6M | $6.0M |
| FY2015 | — | $192.4M | $69.5M |
| FY2016 | — | $136.2M | $22.1M |
| FY2017 | — | $187.9M | $49.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $121.7M | $10.2M |
| FY2014 | — | $206.6M | $6.0M |
| FY2015 | — | $192.4M | $69.5M |
| FY2016 | — | $136.2M | $22.1M |
| FY2017 | — | $187.9M | $49.8M |